Related Experiment Video
Updated: May 31, 2026

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus (MRSA) Infection
Published on: September 1, 2023
Recurrent sterile abscesses following aluminium adjuvant-containing vaccines
Nicola P Klein1, Kathryn M Edwards, Robert C Sparks
1Kaiser PermanenteVaccine Study Center, 16th Floor, One Kaiser Plaza, Oakland, California 94612, USA.
Insights
Recurrent sterile abscesses can occur after vaccination with aluminium adjuvants. This finding suggests a link between aluminium adjuvants and sterile abscesses in some children.
Area of Science:
- Immunology
- Vaccinology
- Pediatrics
Background:
- Abscess formation is a known complication of immunization, often due to vaccine contamination.
- Sterile abscesses, though less common, have also been reported following vaccination.
Purpose of the Study:
- To describe cases of recurrent sterile abscesses in children post-vaccination.
- To investigate the potential association between aluminium-adjuvanted vaccines and sterile abscesses.
Main Methods:
- Case series involving two children evaluated within the Clinical Immunization Safety Assessment (CISA) network.
- Review of clinical history and vaccination records for patients developing sterile abscesses.
Main Results:
- Two children developed recurrent sterile abscesses after receiving vaccines containing aluminium adjuvant.
- Abscesses resolved without long-term complications.
Conclusions:
- The occurrences support an association between aluminium adjuvant receipt and sterile abscess development in susceptible individuals.
- Clinicians may consider using vaccine formulations with lower aluminium content for at-risk patients.
Abstract:
Abscess formation following immunisation is a previously reported complication, generally associated with microbial contamination of the vaccine. Less commonly, such abscesses have been sterile. Here we describe two children evaluated in the Center for Disease Control and Prevention (CDC)-funded Clinical Immunization Safety Assessment (CISA) network who developed recurrent sterile abscesses after administration of vaccines containing aluminium adjuvant, either individually or in combination. Although the abscesses healed without sequelae, these occurrences support an association between receipt of aluminium adjuvant and sterile abscesses in susceptible patients. For patients with similar symptoms, clinicians may wish to choose a vaccine formulation containing the least amount of aluminium adjuvant.
Related Concept Videos
Vaccinations
Brain Abscess l: Introduction
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Vaccines
Staphylococcal Skin Infections
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
